{"organizations": [], "uuid": "0ae238fa0afd60fcc0e6b7c0ec29e87c46d2ce45", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/14/globe-newswire-curative-biosciences-inc-commences-trading-under-symbol-cbdx.html", "country": "US", "domain_rank": 767, "title": "Curative Biosciences Inc. Commences Trading Under Symbol CBDX", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-14T22:03:00.000+02:00", "replies_count": 0, "uuid": "0ae238fa0afd60fcc0e6b7c0ec29e87c46d2ce45"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/14/globe-newswire-curative-biosciences-inc-commences-trading-under-symbol-cbdx.html", "ord_in_thread": 0, "title": "Curative Biosciences Inc. Commences Trading Under Symbol CBDX", "locations": [], "entities": {"persons": [], "locations": [{"name": "fl", "sentiment": "none"}, {"name": "miami", "sentiment": "none"}], "organizations": [{"name": "curative biosciences, inc.", "sentiment": "neutral"}, {"name": "curative biosciences inc", "sentiment": "neutral"}, {"name": "finra", "sentiment": "none"}, {"name": "financial industry regulatory authority", "sentiment": "none"}, {"name": "curative biosciences, inc", "sentiment": "none"}, {"name": "curative biosciences", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Miami, FL, March 14, 2018 (GLOBE NEWSWIRE) -- Curative Biosciences, Inc., (OTCBB: CBDX) (\" Curative \") is pleased to announce that the Financial Industry Regulatory Authority (FINRA) has assigned “CBDX” as the Company's new ticker symbol and it has commenced trading under that symbol today.\nFor information on Curative and the Company’s portfolio of Hemp CBD oil products please visit www.curativebiosciences.com .\nInvestor relations information is available by emailing investors@curativebiosciences.com or by calling (949) 287-3164.\nAbout Curative Biosciences, Inc.\nCurative Biosciences (CBDX), is creating a new category in the health industry by translating advances in science and technology into effective, scientifically sound health products available to people in their everyday lives. We are developing a portfolio of products with compelling compounds found in nature that offer an opportunity for our customers to proactively support their health.\nFORWARD-LOOKING STATEMENTS\nThis press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available at the website maintained by the SEC at http://www.sec.gov .\nContact: www.curativebiosciences.com investors@curativebiosciences.com (949) 287-3164\nSource:Curative Biosciences, Inc", "external_links": ["https://www.globenewswire.com/Tracker?data=vwfQzmSgb-jkLKrbIweBrKHKV5OUFNYgo2QXDIzHhveFwaL8ftzpWKvbWd6HB--lH7qsrXVpBDqmiGiDkgi_yvSoTQPKu9tOTVPp3u7X4JGkRzVR9eVKl317hTP5T55S", "https://www.globenewswire.com/Tracker?data=b-i96XgQkFcqwhSlvHMjqlmYJXj53F7r0OOXN7qZylcUMkxv6wJyILvq8Z0hLnoKGFxQLt0DdWEFWXPk3cBOj2SdSdqOAFr2XjLE2NJ4MdcwxS7U9MEJ4DBvVJlglNDq", "https://www.globenewswire.com/NewsRoom/AttachmentNg/284ed26d-a2ca-41f2-905c-8ba8a01823dd", "https://www.globenewswire.com/Tracker?data=59Dls4dwNzk4Ewgku9tEM4oZQPStPlnGzu3dHt-T6THrGFuEsW47MVXhpM6oKPdzMPqm4iyMF2Q5M6CSHzGbZExsENuX2n7rbw9QxtEo9Xyuod58zKytagAUtyp8PRPXf_wqX3CG43A612NmgcVNqK3osU_KO4KRXksNua2mDs95xIO-lljmKhxpngfYzyGHEHI9iDC9ocondE3m9MwGmOYSGDAqoTIzVAf00ydetr4="], "published": "2018-03-14T22:03:00.000+02:00", "crawled": "2018-03-14T23:10:22.025+02:00", "highlightTitle": ""}